Japanese encephalitis laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Overview== | ==Overview== |
Revision as of 18:38, 27 December 2012
Japanese encephalitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Japanese encephalitis laboratory findings On the Web |
American Roentgen Ray Society Images of Japanese encephalitis laboratory findings |
Risk calculators and risk factors for Japanese encephalitis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Diagnosis is based on a combination of clinical signs and symptoms and specialized laboratory tests of blood or cerebrospinal fluid. It is diagnosed by detection of antibodies in serum and CSF (cerebrospinal fluid) by IgM capture ELISA. Clinical laboratory findings might include a moderate leukocytosis, mild anemia, and hyponatremia. Cerebrospinal fluid (CSF) typically has a mild to moderate pleocytosis with a lymphocytic predominance, slightly elevated protein, and normal ratio of CSF to plasma glucose.